1-4 of 4
April Horne
Close
Sort by
Journal Articles

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng M. Wu, Ian J. Mackie, Marina Noris, Agnes Veyradier, Marie A. Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi
Journal: Blood
Blood (2012) 120 (2): 440–448.
https://doi.org/10.1182/blood-2012-01-403113
Published: 2012
Includes: Supplemental data
Journal Articles

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Luca A Lotta, Haifeng M Wu, Marie A Scully, Marina Noris, Agnes Veyradier, Ian J Mackie, PhD FRCPath, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, MD, Richard A Gibbs, April Horne, Shangbin Yang, Roberta Palla, Flora Peyvandi
Journal: Blood
Blood (2011) 118 (21): 2219.
https://doi.org/10.1182/blood.V118.21.2219.2219
Published: 2011
Journal Articles

Lower ADAMTS13 Activity and Higher Bethesda Units of Antibody Inhibitor in Early Remission Are Associated with a Higher Probability of TTP Exacerbation.

Spero Cataland, Shangbin Yang, April Horne, Shili Lin, James George, MD, Haifeng Wu, MD
Journal: Blood
Blood (2008) 112 (11): 2299.
https://doi.org/10.1182/blood.V112.11.2299.2299
Published: 2008
Journal Articles

Improved Clinical Outcome and ADAMTS13 Activity after Concurrent Cyclosporine and Plasma Exchange in TTP.

Spero R. Cataland, MD, Eric H. Kraut, MD, Don Benson, MD, PhD, Amy K. Ferketich, PhD, April Horne, Ming Jin, PhD, James N. George, MD, Haifeng M. Wu, MD
Journal: Blood
Blood (2006) 108 (11): 1056.
https://doi.org/10.1182/blood.V108.11.1056.1056
Published: 2006